---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-055142"
form_type: "8-K"
ticker: "DOMH"
cik: "0000012239"
company_name: "Dominari Holdings Inc."
filed_at: "2022-09-12T23:59:59+00:00"
generated_at: "2026-06-23T10:46:55.386116+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AIkido Pharma subsidiary Dominari Financial to acquire broker-dealer Fieldpoint Private Securities for $2M

## Summary
- Purchase price $2,000,001 for 100% membership interests of FINRA-registered broker-dealer Fieldpoint Private Securities.
- Two-stage closing: $2M for 20% now, then $1 for remaining 80% upon FINRA Rule 1017 approval.
- Acquisition aims to diversify AIkido beyond biotech into financial services; Dominari Financial launched June 2022.
- Press release: board supports roll-up strategy targeting ultra-high-net-worth wealth management firms.
- If FINRA denies the Rule 1017 application, seller must pay $2M to Dominari and revert the initial 20% membership interests.

## SEC filing metadata
- accession: 0001213900-22-055142
- form_type: 8-K
- ticker: DOMH
- cik: 0000012239
- company_name: Dominari Holdings Inc.
- filed_at: 2022-09-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12239/000121390022055142/0001213900-22-055142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12239/000121390022055142/ea165577-8k_aikidopharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-055142
- JSON: https://secwatch.observer/filing/0001213900-22-055142.json
- Plain text: https://secwatch.observer/filing/0001213900-22-055142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.